Organization
Base Therapeutics
3 clinical trials
Clinical trial
Exploratory Study of NK510 Combined With PD-1 Blockade in the Treatment of Relapsed and Refractory Advanced NSCLCStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Exploratory Study of NK510 Cell Therapy Combined With Monoclonal Antibody in the Treatment of Recurrent and Refractory Advanced Gastric CancerStatus: , Estimated PCD: 2024-11-01
Clinical trial
An Open, Single Center Exploratory Study to Evaluate Safety and Efficacy of NK510 for Patients With Osteosarcoma and Soft Tissue SarcomaStatus: Recruiting, Estimated PCD: 2024-09-01